Machine learning model designed to measure sepsis risk

An AI-based sepsis screening tool could better help physicians find patients most at risk of developing the illness after it outperformed other traditional screening methods, according to a study published in the Annals of Emergency Medicine.

Several healthcare organizations in the United States and United Kingdom have turned to AI solutions to address sepsis in patients and prevent fatal outcomes. Last November, Massachusetts researchers developed an AI system that predicted when critical drugs should be administered to sepsis patients.

For this study, a research team used machine learning to develop and test a sepsis screening tool—called the Risk of Sepsis Score (RoS)—with electronic health record data from emergency room (ER) patients at 49 different urban community hospitals. The data featured about 2.7 million records.

The screening method was analyzed one, three, six, 12 and 24 hours after receiving the data. Additionally, its performance was rated with various metrics—alert rate, area under the receiver operating characteristic curve (AUC), sensitivity, specificity and precision. According to the study, the RoS was the “most discriminant screening tool” when identifying most at-risk patients, and was significantly more sensitive and precise than the next top performing sepsis screening method.

“In this retrospective study, RoS was more timely and discriminant than benchmark screening tools...further study is needed to validate the RoS score at independent sites,” Ryan J. Delahanty, PhD, data scientist at Tenet Healthcare, et al. concluded.

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”